JP2011521979A5 - - Google Patents

Download PDF

Info

Publication number
JP2011521979A5
JP2011521979A5 JP2011511948A JP2011511948A JP2011521979A5 JP 2011521979 A5 JP2011521979 A5 JP 2011521979A5 JP 2011511948 A JP2011511948 A JP 2011511948A JP 2011511948 A JP2011511948 A JP 2011511948A JP 2011521979 A5 JP2011521979 A5 JP 2011521979A5
Authority
JP
Japan
Prior art keywords
pyridine
hydroxymethyl
methyl
hydroxy
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011511948A
Other languages
English (en)
Japanese (ja)
Other versions
JP5514810B2 (ja
JP2011521979A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2009/000787 external-priority patent/WO2009146555A1/en
Publication of JP2011521979A publication Critical patent/JP2011521979A/ja
Publication of JP2011521979A5 publication Critical patent/JP2011521979A5/ja
Application granted granted Critical
Publication of JP5514810B2 publication Critical patent/JP5514810B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011511948A 2008-06-04 2009-06-04 ピリドキシンに由来するhivインテグラーゼ阻害剤 Expired - Fee Related JP5514810B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13087408P 2008-06-04 2008-06-04
US61/130,874 2008-06-06
PCT/CA2009/000787 WO2009146555A1 (en) 2008-06-04 2009-06-04 Hiv integrase inhibitors from pyridoxine

Publications (3)

Publication Number Publication Date
JP2011521979A JP2011521979A (ja) 2011-07-28
JP2011521979A5 true JP2011521979A5 (enExample) 2012-01-05
JP5514810B2 JP5514810B2 (ja) 2014-06-04

Family

ID=41397686

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011511948A Expired - Fee Related JP5514810B2 (ja) 2008-06-04 2009-06-04 ピリドキシンに由来するhivインテグラーゼ阻害剤

Country Status (8)

Country Link
US (1) US8742123B2 (enExample)
EP (1) EP2300433A4 (enExample)
JP (1) JP5514810B2 (enExample)
CN (1) CN102112447B (enExample)
AU (1) AU2009253812A1 (enExample)
CA (1) CA2726742A1 (enExample)
RU (1) RU2010153656A (enExample)
WO (1) WO2009146555A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8410300B2 (en) 2006-09-21 2013-04-02 Taimed Biologics, Inc. Protease inhibitors
JP2010523476A (ja) 2007-03-08 2010-07-15 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ ミトコンドリアアルデヒドデヒドロゲナーゼ−2モジュレーター及びその使用方法
CN102209541B (zh) 2008-09-08 2016-05-18 小利兰·斯坦福大学托管委员会 醛脱氢酶活性调节剂和其使用方法
JP2012506856A (ja) 2008-10-28 2012-03-22 ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ アルデヒドデヒドロゲナーゼのモジュレーターおよびその使用方法
US8283366B2 (en) * 2010-01-22 2012-10-09 Ambrilia Biopharma, Inc. Derivatives of pyridoxine for inhibiting HIV integrase
US10457659B2 (en) 2011-04-29 2019-10-29 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for increasing proliferation of adult salivary stem cells
WO2013102145A1 (en) 2011-12-28 2013-07-04 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
JP6242810B2 (ja) 2011-12-28 2017-12-06 グローバル・ブラッド・セラピューティクス・インコーポレイテッドGlobal Blood Therapeutics,Inc. 置換ベンズアルデヒド化合物および組織酸素化の増加におけるそれらの使用方法
KR20150135332A (ko) * 2013-03-14 2015-12-02 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 미토콘드리아 알데히드 탈수소효소-2 조절인자들 및 이들의 사용 방법
SG11201507320QA (en) 2013-03-15 2015-10-29 Global Blood Therapeutics Inc Compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
ES2993155T3 (en) 2013-03-15 2024-12-23 Global Blood Therapeutics Inc Compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10100043B2 (en) 2013-03-15 2018-10-16 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
SG11201507453VA (en) 2013-03-15 2015-10-29 Global Blood Therapeutics Inc Compounds and uses thereof for the modulation of hemoglobin
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
PL3102208T5 (pl) 2014-02-07 2024-10-14 Global Blood Therapeutics, Inc. Krystaliczny polimorf wolnej zasady 2-hydroksy-6-((2-(1-izopropylo-1h-pirazol-5-ilo)pirydyn-3-ylo)metoksy)benzaldehydu
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
ES3039236T3 (en) 2015-12-04 2025-10-20 Global Blood Therapeutics Inc Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
TW202246215A (zh) 2015-12-18 2022-12-01 美商亞德利克斯公司 作為非全身tgr5促效劑之經取代之4-苯基吡啶化合物
US12084472B2 (en) 2015-12-18 2024-09-10 Ardelyx, Inc. Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
TWI752307B (zh) 2016-05-12 2022-01-11 美商全球血液治療公司 新穎化合物及製造化合物之方法
TW202332423A (zh) 2016-10-12 2023-08-16 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
CN108203439B (zh) * 2016-12-20 2020-04-14 四川大学 苯乙烯吡啶类化合物、其制备方法和用途
RU2641309C1 (ru) * 2017-07-24 2018-01-17 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Антисептическое лекарственное средство
EP3687538B1 (en) * 2017-10-30 2024-04-17 Montreal Heart Institute Methods of treating elevated plasma cholesterol
US11014884B2 (en) 2018-10-01 2021-05-25 Global Blood Therapeutics, Inc. Modulators of hemoglobin
US12404260B2 (en) * 2019-04-11 2025-09-02 Janssen Pharmaceutica Nv Pyridine rings containing derivatives as MALT1 inhibitors
WO2020237374A1 (en) * 2019-05-28 2020-12-03 Montreal Heart Institute Picolinic acid derivatives and use thereof for treating diseases associated with elevated cholesterol
CN113116890B (zh) * 2021-04-25 2022-06-03 西南大学 5-Pyridoxolactone用于制备抑制家蚕核型多角体病毒的药物中的应用
CN117343006B (zh) * 2023-10-08 2024-07-09 河南科技大学 一种arb-272572的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107291A (en) 1997-12-19 2000-08-22 Amgen Inc. Azepine or larger medium ring derivatives and methods of use
ATE260255T1 (de) * 1998-11-05 2004-03-15 Pfizer Prod Inc 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
PA8586801A1 (es) 2002-10-31 2005-02-04 Pfizer Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
EP1656348B1 (en) * 2003-08-20 2007-02-07 Axys Pharmaceuticals, Inc. Acetylene derivatives as inhibitors of histone deacetylase
CA2564356A1 (en) * 2004-04-26 2005-11-03 Pfizer Inc. Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors
US8114886B2 (en) * 2005-04-08 2012-02-14 Daiichi Sankyo Company, Limited Pyridylmethylsulfone derivative

Similar Documents

Publication Publication Date Title
JP2011521979A5 (enExample)
RU2010153656A (ru) Ингибиторы интегразы вич из пиридоксина
US9790183B2 (en) Pyridyl inhibitors of hedgehog signalling
JP4818798B2 (ja) Ccr9インヒビターおよびその使用方法
US6835731B2 (en) Chemokine receptor binding heterocyclic compounds
US20020193377A1 (en) Quinazolines as MMP-13 inhibitors
ES2344347T3 (es) Derivados de cianopiridina novedosos utiles en el tratamiento de cancer y otros trastornos.
AU694465B2 (en) Anthranilic acid derivative
US9096527B2 (en) TRPM8 antagonists and their use in treatments
US20070155744A1 (en) N-benzyl-3,4-dihyroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4- carboxamide compounds useful as hiv integrase inhibitors
US20050267119A1 (en) Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
SK9612000A3 (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
US20170015627A1 (en) Pyridyl inhibitors of hedgehog signalling
US9060515B2 (en) Heterocyclic urea compounds
IE41838L (en) 4-(n-heterocyclic)-quinazolines; cardiac stimulants
CA2437409A1 (en) Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
JPH1029979A (ja) 新規ピリジン誘導体
US20220143020A1 (en) 2-aminoquinazolinone derivative
JP7510520B2 (ja) 新規なリンカーで結合された少なくとも2種のアリール又はヘテロアリールを含むカルボノヒドラゾノイルジシアニド化合物及びその用途
US20080293696A1 (en) 2-Aminoarylcarboxamides Useful as Cancer Chemotherapeutic Agents
CN119585255A (zh) 杂芳基衍生化合物及其用途
AU2007209981A1 (en) Potassium channel inhibitors
US6720315B2 (en) Dihydrostilbene alkanoic acid derivatives
MX2014001052A (es) Compuesto novedoso que tiene actividad inhibidora de angiogénesis, metodo para preparar del mismo, y composicion farmaceutica que comprende el mismo.
JP2003502423A (ja) チオフェン−エチル−チオウレア化合物およびhivの治療におけるその使用